Nasdaq

Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens

PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...
Healio

FDA approves Alcon’s AcrySof IQ PanOptix trifocal IOL

Please provide your email address to receive an email when new articles are posted on . PanOptix, which is already available in more than 70 countries, has been shown to deliver a combination of near, ...
Nasdaq

Alcon to Highlight AcrySof IQ PanOptix Trifocal IOL Launch and Groundbreaking IOL Data at American Academy of Ophthalmology Annual Meeting

PanOptix, the first and only advanced trifocal lens for U.S. patients undergoing cataract surgery, will be showcased in educational events and clinical data presentations First-ever analyses on IOLs ...
Seeking Alpha

Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter

GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...
Healio

Patient satisfaction high with PanOptix trifocal IOL

Please provide your email address to receive an email when new articles are posted on . KOLOA, Hawaii — Patients who received the newly approved PanOptix trifocal lens reported high levels of ...
The Financial

Alcon AcrySof IQ PanOptix trifocal intraocular lens shows superior visual performance in head-to-head trial post-cataract surgery

The FINANCIAL — Basel, June 18, 2018 Alcon, the global leader in eye care and a division of Novartis, unveils new data showing significantly improved near and intermediate distance vision with the ...
Hosted on MSN

Alcon Inc (ALC) Announces Approval of Clareon PanOptix Pro Intraocular Lens

Alcon Inc. (NYSE:ALC) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 20, Alcon Inc. (NYSE:ALC) announced the approval of the Clareon PanOptix Pro intraocular lens for patients in ...
Business Insider

GSNVI Offering First FDA Approved Trifocal IOL – PanOptix

San Diego, Ca, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Gordon Schanzlin New Vision Institute, a TLC Laser Eye Center, leads the forefront of vision technology in San Diego with their newest Intraocular ...
Seeking Alpha

Alcon Introduces Clareon PanOptix Pro in Canada, Delivering the Lowest Light Scatter of any Trifocal IOL

The Clareon PanOptix Pro Trifocal IOL is a type of multifocal IOL used to focus images clearly onto the back of your eye (retina) to allow clear vision after the cataract removal. In addition, the ...
Business Insider

Dr. Scott Perkins of Barnet Dulaney Perkins Eye Center Is First In Arizona to Implant Alcon's Acrysof IQ PanOptix Trifocal IOL, a New Solution for Presbyopia

PHOENIX, Sept. 3, 2019 /PRNewswire-PRWeb/ -- Barnet Dulaney Perkins Eye Center, an American Vision Partners affiliate, is the first practice in Arizona to provide a new solution for patients with ...
Business Wire

Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens

PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...